.svg){kind=small}
Apr-2025
Sales
Trend
6-Month
Product Count
SKUs
Overview
Market Insights Snapshot
Kind Medicine has shown a consistent presence in the California market, particularly within the Tincture & Sublingual category. After not ranking in January 2025, the brand made a notable entry into the top 20 in February and maintained its position in March and April. This upward movement indicates a growing acceptance and demand for Kind Medicine's products in this category, which is further corroborated by the increase in sales from January to February. However, the slight dip in sales from March to April suggests a potential plateau or increased competition within the category.
While Kind Medicine's performance in the Tincture & Sublingual category in California is commendable, the absence of rankings in January highlights a period where the brand was not among the top 30. This could suggest challenges in market penetration or lower brand visibility at the beginning of the year. Despite this, their subsequent rise in rank demonstrates effective strategies in capturing market share. Observers might find it interesting to explore what strategic changes were implemented between January and February that facilitated this rise, as such insights could offer valuable lessons for other brands aiming to improve their standings in competitive markets.
Competitive Landscape
In the competitive landscape of the Tincture & Sublingual category in California, Kind Medicine has experienced fluctuating rankings, indicating a dynamic market presence. Notably, Kind Medicine was ranked 18th in February 2025, improved to 17th in March, but slipped back to 18th in April. This suggests a slight upward trend followed by stabilization, though they remain outside the top 15. Competitors such as Carter's Aromatherapy Designs (C.A.D.) consistently hold the 12th position, indicating a strong foothold in the market. Meanwhile, Breez and High Power have shown varied performance, with Breez not ranking after January and High Power re-entering the top 20 at 16th in April. These shifts highlight the competitive pressures Kind Medicine faces, particularly from brands like C.A.D. that maintain steady sales and ranking positions. The data suggests that while Kind Medicine is making incremental progress, there is significant room for growth to challenge the more dominant brands in this category.
Notable Products
In April 2025, the Indica Tincture (800mg THC, 30ml) emerged as the top-performing product for Kind Medicine, reclaiming its number one spot after a brief dip in February. This product saw a notable increase in sales, reaching 125 units. The Sativa Tincture (800mg THC, 30ml), which had consistently held the top rank in February and March, slipped to second place despite strong sales. Meanwhile, the CBD:THC 20:1 Tincture (450mg CBD, 22.4mg THC 30ml) maintained its steady third-place position throughout the months. New to the rankings in April, the Indica Capsules 10-Pack (300mg) entered at fifth place, marking its debut in the sales data.
Top Selling Cannabis Brands
Data for this report comes from real-time sales reporting by participating cannabis retailers via their point-of-sale systems, which are linked up with Headset’s business intelligence software. Headset’s data is very reliable, as it comes digitally direct from our partner retailers. However, the potential does exist for misreporting in the instance of duplicates, incorrectly classified products, inaccurate entry of products into point-of-sale systems, or even simple human error at the point of purchase. Thus, there is a slight margin of error to consider. Brands listed on this page are ranked in the top twenty within the market and product category by total retail sales volume.
